Epikast
Latest round
- Series B
Last raised
- Jan 2026
Total raised
- $0.7M
Investors
- 1
About Epikast
Based in the US, Epikast Inc.Epikast Inc. specializes in advanced healthcare engagement solutions. Founded in 2022, the company has completed two deal to date. The firm is headquartered in the United States and was established to address the communication needs within the healthcare sector. In January 2026, Epikast Inc.Epikast specializes in providing advanced healthcare engagement solutions through its core offerings, which include medically trained talent and proprietary AI-driven engagement tools. The company's services enhance interactions with key stakeholders in the biopharma and healthcare sectors, specifically targeting patients, physicians, and healthcare providers across the United States and Europe. Epikast's peer-to-peer engagement model is designed to drive impactful communication, reduce operational costs, and enhance product performance. The offerings facilitate real-time insights for clients, enabling them to refine their strategies and messaging based on feedback from healthcare professionals and patients.Epikast generates revenue primarily through partnerships and contractual agreements with biopharma and healthcare organizations. The company’s engagement model typically involves a structured pricing plan, where clients invest in tailored solutions that include access to expert teams and proprietary AI tools designed for specific healthcare outcomes. Transactions are primarily B2B, focusing on collaborations that allow organizations to enhance their communication with healthcare professionals and patients. Revenue is derived from these partnerships, which may include fixed fees for services rendered, subscription models for ongoing access to AI-driven insights, and performance-based incentives tied to the effectiveness of the engagement strategies implemented. Specific pricing plans for individual services and products are structured to meet the varying needs of their diverse clientele, ensuring flexibility and adaptability in their approach. In January 2026, Epikast Inc. Future plans include the launch of new products aimed at enhancing healthcare engagement solutions. The company is also targeting expansion into additional markets within Europe and North America by 2026.
Who invested in Epikast
1 investor across 1 round
See all investors in Epikast
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series B
Jan 22, 2026
Amount
$0.7M
Investors
Questions about Epikast
Who invested in Epikast?
Epikast has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Epikast raised?
Epikast has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Epikast last raise money?
Epikast's most recent round on record is a Series B, in Jan 2026.
What does Epikast do?
Epikast is a software company.
Where is Epikast headquartered?
Epikast is headquartered in Brooklyn, US.
Which VCs invest in companies like Epikast?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back software companies at Epikast's stage. Their profiles are linked below.
VCs backing software startups at Series B
Raising like Epikast? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.